Negotiated Medicare Drug Prices Could Impact Drugmakers’ Profits and Innovation
Trenton, New Jersey – President Joe Biden’s Inflation Reduction Act includes a crucial policy focusing on Medicare drug-price negotiations to alleviate the burden of expensive medications on seniors. The act aims to make these medications more affordable for the elderly population, potentially impacting drugmakers’ profits. In light of this initiative, final negotiated prices for the initial round of drugs subject to these negotiations, involving companies like J&J and Bristol Myers, are set to take effect …